Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Valent

Showing results (131-140 of 662) with videos related to

Pageof 67
Sort By:
AJR. American Journal of Roentgenology|October 22, 2002
FDG positron emission tomography in patients with systemic mastocytosisGeorg Zettinig, Alexander Becherer, Monika Szabo, et al.
Annual Review of Pharmacology and Toxicology|October 24, 2014
Novel targeted therapies for eosinophil-associated diseases and allergySusanne Radonjic-Hoesli, Peter Valent, Amy D Klion, et al.
Leukemia Research|October 5, 2002
Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemiaKarl Sotlar, Claudius Fridrich, Adelheid Mall, et al.
Leukemia & Lymphoma|April 12, 2003
Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugsPuchit Samorapoompichit, Marianne Steiner, Trevor Lucas, et al.
Haematologica|October 12, 2010
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg dailyMaria-Theresa Krauth, Susanne Herndlhofer, Maria-Theresa Schmook, et al.
Leukemia & Lymphoma|September 14, 2004
Bone marrow microvessel density and its prognostic significance in AMLWerner Rabitsch, Wolfgang R Sperr, Klaus Lechner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Impact of age and comorbidity in myelodysplastic syndromesReinhard Stauder, Thomas Nösslinger, Michael Pfeilstöcker, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 1, 2023
Genetic Variants Leading to Urticaria and Angioedema and Associated BiomarkersJonathan J Lyons, Henriette Farkas, Anastasios E Germenis, et al.
International Journal of Hematology|June 4, 2002
Signal transduction-associated and cell activation-linked antigens expressed in human mast cellsPeter Valent, Minoo Ghannadan, Alexander W Hauswirth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapseWolfgang R Sperr, Margit Mitterbauer, Gerlinde Mitterbauer, et al.
Pageof 67

Showing results (131-140 of 662) with videos related to

Sort By:
Pageof 67
AJR. American Journal of Roentgenology|October 22, 2002
FDG positron emission tomography in patients with systemic mastocytosisGeorg Zettinig, Alexander Becherer, Monika Szabo, et al.
Annual Review of Pharmacology and Toxicology|October 24, 2014
Novel targeted therapies for eosinophil-associated diseases and allergySusanne Radonjic-Hoesli, Peter Valent, Amy D Klion, et al.
Leukemia Research|October 5, 2002
Detection of c-kit point mutation Asp-816 --> Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemiaKarl Sotlar, Claudius Fridrich, Adelheid Mall, et al.
Leukemia & Lymphoma|April 12, 2003
Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugsPuchit Samorapoompichit, Marianne Steiner, Trevor Lucas, et al.
Haematologica|October 12, 2010
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg dailyMaria-Theresa Krauth, Susanne Herndlhofer, Maria-Theresa Schmook, et al.
Leukemia & Lymphoma|September 14, 2004
Bone marrow microvessel density and its prognostic significance in AMLWerner Rabitsch, Wolfgang R Sperr, Klaus Lechner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Impact of age and comorbidity in myelodysplastic syndromesReinhard Stauder, Thomas Nösslinger, Michael Pfeilstöcker, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 1, 2023
Genetic Variants Leading to Urticaria and Angioedema and Associated BiomarkersJonathan J Lyons, Henriette Farkas, Anastasios E Germenis, et al.
International Journal of Hematology|June 4, 2002
Signal transduction-associated and cell activation-linked antigens expressed in human mast cellsPeter Valent, Minoo Ghannadan, Alexander W Hauswirth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2005
Quantitation of minimal residual disease in acute myeloid leukemia by tryptase monitoring identifies a group of patients with a high risk of relapseWolfgang R Sperr, Margit Mitterbauer, Gerlinde Mitterbauer, et al.
Pageof 67